Morocco Tops Drug Distribution Profit Margins, Surpassing France, Spain, and Portugal
A recent report revealed that Morocco records the highest profit margins in drug distribution compared to several European countries, including France, Spain, and Portugal, highlighting the unique characteristics of the pharmaceutical market in the kingdom.
The report indicated that the profit margin applicable in Morocco’s drug distribution chain, which includes distributors and pharmacists, remains relatively higher compared to the systems adopted in some European countries, where prices are subject to stricter regulation by health authorities.
Observers note that these margins are related to several factors, including the structure of the drug market in Morocco, distribution and logistics costs, as well as the nature of the regulatory framework used to determine drug prices and their associated profit margins.
Experts also point out that a higher profit margin does not necessarily mean that drug prices in Morocco are the highest. The final consumer price is influenced by various factors, such as production costs, import fees, taxes, and government pricing policies.
This discussion brings to the forefront the need for reforming the drug pricing system in Morocco, amidst ongoing calls to achieve a balance between ensuring the sustainability of the distribution chain and enabling citizens to access medicines at reasonable prices.
